Omalizumab drug survival in chronic urticaria: a retrospective multicentric French study.

Auteurs : Litovsky J, Hacard F, Tetart F, Boccon-Gibod I, Soria A, Staumont-Salle D, et al.

Revue : The Journal of Allergy and Clinical Immunology In Practice.

Année : 2023

Groupe : RecSaN